What development phase is VANGLUSAGENE ENSIPARVOVEC in?

VANGLUSAGENE ENSIPARVOVEC is in Phase 1.

Last reviewed 2026-04-20 · How we verify

VANGLUSAGENE ENSIPARVOVEC

Phase 1 active Gene therapy Quality 0/100

At a glance

Generic name	VANGLUSAGENE ENSIPARVOVEC
Modality	Gene therapy
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

VANGLUSAGENE ENSIPARVOVEC CI brief — competitive landscape report
VANGLUSAGENE ENSIPARVOVEC updates RSS · CI watch RSS